Müller-Wieland, D

[New, expensive antidiabetics for the treatment of type-2 diabetes--pro]. [electronic resource] - Deutsche medizinische Wochenschrift (1946) May 2010 - 922 p. digital

Publication Type: Journal Article

1439-4413

10.1055/s-0030-1253679 doi


Blood Glucose--metabolism
Cost-Benefit Analysis--statistics & numerical data
Diabetes Mellitus, Type 2--blood
Drug Approval--economics
Drug Costs--statistics & numerical data
Evidence-Based Medicine
Germany
Humans
Hypoglycemia--blood
Hypoglycemic Agents--adverse effects
National Health Programs--economics
Treatment Outcome